Wegovy is also used to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with known cardiovascular disease and with either obesity or overweight
Additionally, GLP-1 therapies suppress glucagon, a hormone that normally elevates blood sugar, further enhancing glucose regulation
(ADD-ONS available upon request during Physician consultation) Contains: Fluids, Electrolytes, B-Complex, Taurine, Amino-Blend Beauty starts from the inside out
The FDA has issued specific warnings about compounded semaglutide products, particularly those using semaglutide sodium salt, which may contain impurities, incorrect dosages, or entirely different substances than labeled
doi: 10.1073/pnas.0909122107 35 NilssonNEKotarskyKOwmanCOldeB
Takeaways for Employers and Benefit Consultants As GLP-1 medications continue to reshape consumer behavior, benefit consultants have a unique opportunity to lead the conversation: Reevaluate coverage for GLP-1 medications, especially as their benefits extend beyond weight loss
.webp)
